Table 5.
Encapsulated | Infiltrative | Total | |
---|---|---|---|
FNAC alone | 22/30 (73%) | 23/29 (79%) | 45/59 (76%) |
FNAC & galectin-3 | 1/11 (9%) | 27/27 (100%) | 28/38 (74%) |
FNAC & BRAF mutation | 22/30 (73%) | 23/28 (82%) | 45/58 (78%) |
FNAC & RAS mutation | 26/28 (93%) | 23/26 (89%) | 49/54 (91%) |
FNAC & somatic mutation | 27/29 (93%) | 25/28 (89%) | 52/57 (91%) |
FNAC, fine-needle aspiration cytology; triage efficacy, defined as classification of an FNAC as papillary thyroid carcinoma, suspicious for malignancy, or follicular neoplasm.